Posted on 10/9/20
Bristol-Myers Squibb: FDA Inspection Secured
SummarySheep of Wall Street posted pictures of a supposed plant visit by FDA inspectors that's crucial to the Bristol-Myers/Celgene milestone.The photos have been met with some . . .
Posted on 10/7/20
AzurRx BioPharma CEO Issues Letter to Shareholders
NEW YORK, Oct. 07, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today . . .
Posted on 10/7/20
Enterprise Therapeutics Acquired By Rochee
Epidarex Capital, a transatlantic life science venture firm, announces that the lead program of its portfolio company Enterprise Therapeutics Ltd has been fully acquired by Roche
Posted on 10/7/20
Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says
The head of the U.S. government's Operation Warp Speed COVID-19 vaccine program, Moncef Slaoui, said he expects phase 3 clinical trial data for multiple coronavirus vaccines . . .
Posted on 10/7/20
SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock
STAMFORD, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe . . .
Posted on 10/6/20
Talaris Therapeutics Closes $115 Million Series B Financing
Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to induce durable immune tolerance across
Posted on 10/6/20
Report: Moderna and Pfizer Vaccine Trial Participants Report Serious Side Effects
Three patients taking part in clinical trials for Moderna's (NASDAQ:MRNA) coronavirus vaccine candidate and two taking part in Pfizer's (NYSE:PFE) study have experienced intense side effects, . . .
Posted on 10/6/20
Pfizer and BioNTech Have Enrolled 83% of Their Up-Sized Coronavirus Vaccine Trial
Pfizer (NYSE:PFE) has now enrolled 36,576 participants in the late-stage clinical trial of its coronavirus vaccine candidate, BNT162b2, which it's developing with BioNTech (NASDAQ:BNTX). Last month, . . .
Posted on 10/6/20
Pfizer, BioNTech, and Regeneron Hit With Patent Lawsuits Over COVID-19 Drugs and Vaccines
Three top names in the fight against the coronavirus and the COVID-19 disease that can result from it have been sued for patent infringement. The trio . . .
Posted on 10/6/20
Report: Johnson & Johnson Paying Over $100 Million to Settle Baby Powder Lawsuits
Johnson & Johnson (NYSE:JNJ) appears to be reaching deep into its coffers to settle a clutch of lawsuits. According to an article published on Monday by . . .
Posted on 10/6/20
Why Regeneron Pharmaceuticals Shot 7% Higher on Monday
What happenedLate last week, Regeneron Pharmaceuticals' (NASDAQ:REGN) experimental COVID-19 treatment was administered to President Donald Trump. Perhaps it helped; Trump tweeted that he was "feeling really . . .
Posted on 10/5/20
What If Pfizer's and Moderna's Coronavirus Vaccine Results Are Delayed?
The countdown is on -- and I'm not referring to the U.S. elections. Many Americans anxiously await the results from the first round of coronavirus vaccines . . .
Posted on 10/1/20
Johnson & Johnson Acquires Momenta Pharmaceuticals for $6.5B
Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc., a company that discovers and develops novel
Posted on 10/1/20
DiamiR Awarded $3.86M in Two Grants from the NIH
DiamiR, a developer of innovative blood-based diagnostic solutions for brain health and other indications, announced today that the National Institute on Aging (NIA) of the National . . .
Posted on 10/1/20
Phreesia Acquires Patient Care Applications From Merck and Geisinger
NEW YORK--(BUSINESS WIRE)--Phreesia, the nation’s leading patient intake platform, is pleased to announce that it has acquired two web-based workflow applications co-developed by Geisinger, a large . . .
Posted on 10/1/20
Why Celldex Has Been A Big Winner In 2020
SummaryCelldex stock rose sharply after CDX-0159 data was announced in June.CDX-527 Phase 1 trial is now underway.Top line CD-3379 Phase 2 data should arrive before year-end.Celldex . . .
Posted on 10/1/20
Better Buy: GlaxoSmithKline vs. Pfizer
Have all of the stocks of drugmakers in the coronavirus vaccine race delivered solid gains so far this year? Nope. GlaxoSmithKline's (NYSE:GSK) adjuvant is being used . . .
Posted on 9/30/20
Interview with Ted Quinn, CEO & Founder of Activate Care
Ted Quinn is the CEO and Co-founder of Activate Care, a digital health company helping everybody engaged in
Posted on 9/30/20
Biophytis Announces A € 10 Million Capital Increase Through Private Placement
Biophytis SA, a clinical-stage biotechnology company specialized in the development of drug candidates for the treatment of aged related diseases, including neuromuscular diseases, today announced a . . .
Posted on 9/30/20
Flame Biosciences Announces $100M Financing
Flame Biosciences, a clinical-stage biopharmaceutical company focused on developing antibodies to treat cancer and inflammatory diseases, announced today the completion of a $100 million common stock . . .
Posted on 9/30/20
Enhanced Healthcare Partners Invest in NeuroPsychiatric Hospitals
NEW YORK--(BUSINESS WIRE)--Enhanced Healthcare Partners, a leading healthcare-focused private equity firm specializing in middle-market healthcare services businesses, is pleased to announce its investment in NeuroPsychiatric Hospitals, . . .
Posted on 9/30/20
Citi Partners with Truvalue Labs
NEW YORK--(BUSINESS WIRE)--Citi today announced a collaboration with Truvalue Labs, the pioneer in AI-driven environmental, social, and governance (ESG) data, to accelerate its ESG research initiatives . . .
Posted on 9/30/20
Major Global Banks Invest $20 Million in BioCatch
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--BioCatch, the global leader in behavioral biometrics, today announced that four major global banks – Barclays, Citi, HSBC and National . . .
Posted on 9/30/20
MeaningCloud Announces Spin-Off Completion of AI Business to Konplik Health
MeaningCloud, today announced the completion of a spin-off from its Artificial Intelligence (AI) businesses into a new
Posted on 9/30/20
PMV Pharma Closes $243.5M IPO
CRANBURY, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting . . .
New York
